Seer Inc (SEER) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.89 (-1.56%), Market cap $0.09B, 52-week low–high $1.66 ~ $2.37.
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-M
Financial statements, price targets, institutional (13F) holdings and related news for Seer Inc are updated in real time on BlackAll Trade.
Seer Inc trades at $1.89 (-1.56%). Real-time quotes and charts are available on BlackAll Trade.
Seer Inc has a market cap of about $0.09B.
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, a